| Kraig M Burgess, DO | |
|
18555 N 79th Ave Ste E101, Glendale, AZ 85308-8392 | |
| (602) 648-5444 | |
| (602) 772-3801 |
| Full Name | Kraig M Burgess |
|---|---|
| Gender | Male |
| Speciality | Hand Surgery |
| Experience | 25 Years |
| Location | 18555 N 79th Ave Ste E101, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396735882 | NPI | - | NPPES |
| 954348 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 4169 (Arizona) | Secondary |
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 4169 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bhsm Rehabilitation Llc | 2062773138 | 1258 |
| Orthopedic Specialists Of North America Pllc | 7719014505 | 270 |
News Archive
New research has revealed that the drug Prasugrel produced by drug company Eli Lilly increases the risk of serious bleeding when compared to the standard therapy.
Stressgen Biotechnologies announced today that the U.S. Patent and Trademark Office granted Patent Number 6,921,534 covering fusion protein compositions comprised of a hepatitis B virus (HBV) antigen fused to a heat shock protein (Hsp), as well as DNA encoding such fusion proteins, and methods of treating an HBV infection using these fusion proteins.
Drugs for type 2 diabetes can contribute to weight gain, bone fractures and cardiovascular problems, but in mice, an investigational drug appears to improve insulin sensitivity without those troublesome side effects, researchers at Washington University School of Medicine in St. Louis have shown.
Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston, MA on Wednesday, September 9, 2009 at 3:50 p.m. ET.
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
› Verified 7 days ago
| Entity Name | Orthopedic Specialists Of North America Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770812828 PECOS PAC ID: 7719014505 Enrollment ID: O20100428000061 |
News Archive
New research has revealed that the drug Prasugrel produced by drug company Eli Lilly increases the risk of serious bleeding when compared to the standard therapy.
Stressgen Biotechnologies announced today that the U.S. Patent and Trademark Office granted Patent Number 6,921,534 covering fusion protein compositions comprised of a hepatitis B virus (HBV) antigen fused to a heat shock protein (Hsp), as well as DNA encoding such fusion proteins, and methods of treating an HBV infection using these fusion proteins.
Drugs for type 2 diabetes can contribute to weight gain, bone fractures and cardiovascular problems, but in mice, an investigational drug appears to improve insulin sensitivity without those troublesome side effects, researchers at Washington University School of Medicine in St. Louis have shown.
Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston, MA on Wednesday, September 9, 2009 at 3:50 p.m. ET.
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kraig M Burgess, DO Po Box 80217, Phoenix, AZ 85060-0217 Ph: (602) 385-2115 | Kraig M Burgess, DO 18555 N 79th Ave Ste E101, Glendale, AZ 85308-8392 Ph: (602) 648-5444 |
News Archive
New research has revealed that the drug Prasugrel produced by drug company Eli Lilly increases the risk of serious bleeding when compared to the standard therapy.
Stressgen Biotechnologies announced today that the U.S. Patent and Trademark Office granted Patent Number 6,921,534 covering fusion protein compositions comprised of a hepatitis B virus (HBV) antigen fused to a heat shock protein (Hsp), as well as DNA encoding such fusion proteins, and methods of treating an HBV infection using these fusion proteins.
Drugs for type 2 diabetes can contribute to weight gain, bone fractures and cardiovascular problems, but in mice, an investigational drug appears to improve insulin sensitivity without those troublesome side effects, researchers at Washington University School of Medicine in St. Louis have shown.
Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopedic device industry and other medical markets, announced today that Brian S. Moore, President and Chief Executive Officer, and Fred L. Hite, Senior Vice President and Chief Financial Officer, are scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston, MA on Wednesday, September 9, 2009 at 3:50 p.m. ET.
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
› Verified 7 days ago
Louis Pak-shun Vu, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5310 W Thunderbird Rd, Suite 110, Glendale, AZ 85306 Phone: 602-865-4510 Fax: 602-865-6100 | |
Brent Paul Hansen, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6320 W Union Hills Dr Ste 1800, Glendale, AZ 85308 Phone: 480-420-0749 Fax: 480-420-0732 | |
Edward P Fink, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5310 W Thunderbird Rd, Suite 110, Glendale, AZ 85306 Phone: 602-865-4510 | |
Dr. John R Ehteshami, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 20280 N 59th Ave Ste 115-345, Glendale, AZ 85308 Phone: 602-377-2616 Fax: 480-656-1554 | |
Dr. David Ryan Burk, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7330 N 99th Ave Ste 200a, Glendale, AZ 85307 Phone: 602-406-3400 Fax: 602-406-0270 | |
Dr. Stephen W Ripple, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5605 W Eugie Ave, Ste 111, Glendale, AZ 85304 Phone: 602-298-8888 Fax: 602-978-4129 |